Trials / Unknown
UnknownNCT06120647
Molecular Mechanisms Underpinning Sarcopenic Obesity
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- The Swedish School of Sport and Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
The coexistence of obesity and sarcopenia results in sarcopenic obesity, a high-risk geriatric condition associated with metabolic perturbations and several co-morbidities. Despite the rising numbers of older adults diagnosed with sarcopenic obesity, few studies have characterized this condition on the muscle cell and systemic level. This study sought to comprehensively assess the influence of sarcopenic obesity on muscle and blood-related parameters and compare it to non-sarocopenic obese and non-sarcopenic lean older adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Essential amino acids (EAA) | intake of 240 mg EAA per kg lean body mass after a resistance exercise session |
Timeline
- Start date
- 2020-01-28
- Primary completion
- 2025-12-15
- Completion
- 2025-12-30
- First posted
- 2023-11-07
- Last updated
- 2023-12-11
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT06120647. Inclusion in this directory is not an endorsement.